Suppr超能文献

产碳青霉烯酶的碳青霉烯类耐药肠杆菌科定植的流行病学特征。

Epidemiological Characteristics of Carbapenemase Producing Carbapenem-Resistant Enterobacteriaceae Colonization.

机构信息

College of Nursing, Pusan National University, Republic of Korea.

Department of Nursing, Pusan National University Yangsan Hospital, Republic of Korea.

出版信息

Asian Nurs Res (Korean Soc Nurs Sci). 2022 Aug;16(3):134-139. doi: 10.1016/j.anr.2022.05.002. Epub 2022 May 20.

Abstract

PURPOSE

This study identified the epidemiological characteristics, including the size and major strains, of carbapenemase-producing carbapenem-resistant Enterobacteriaceae (CP-CRE) and CP-CRE-related factors by comparing the characteristics of patients in the CP-CRE and non-CP-CRE groups and the CP-CRE and non-CRE groups.

METHODS

This secondary data analysis study included 24 patients in the CP-CRE group, 113 patients in the non-CP-CRE group, and 113 in the non-CRE group. The size and type of CP-CRE were analyzed in terms of frequency and percentage, and CP-CRE risk factors were identified using multiple logistic regression analysis.

RESULTS

The rate of CP-CRE positivity among patients with CRE was 17.5%, and the most common causative organism in the CP-CRE group was Klebsiella pneumoniae (81.8%). There were no significant differences between patients in the CP-CRE and non-CP-CRE groups. When compared with the non-CRE group, the isolation of multidrug-resistant organisms except for CRE, particularly vancomycin-resistant Enterococcus, was confirmed as a major risk factor.

CONCLUSION

To prevent CP-CRE acquisition, patients with multidrug-resistant organisms require treatment with more thorough adherence to CRE prevention and management guidelines.

摘要

目的

本研究通过比较产碳青霉烯酶的碳青霉烯类耐药肠杆菌科(CP-CRE)患者与非 CP-CRE 患者以及 CP-CRE 与非 CRE 患者的特征,确定 CP-CRE 的流行病学特征,包括规模和主要菌株,以及 CP-CRE 相关因素。

方法

本二次数据分析研究纳入了 24 例 CP-CRE 组患者、113 例非 CP-CRE 组患者和 113 例非 CRE 组患者。采用频率和百分比分析 CP-CRE 的规模和类型,并采用多因素 logistic 回归分析确定 CP-CRE 的危险因素。

结果

CRE 患者中 CP-CRE 阳性率为 17.5%,CP-CRE 组中最常见的病原体为肺炎克雷伯菌(81.8%)。CP-CRE 组和非 CP-CRE 组患者之间无显著差异。与非 CRE 组相比,除 CRE 外,多药耐药菌的分离,特别是耐万古霉素肠球菌,被确认为主要危险因素。

结论

为了预防 CP-CRE 的发生,需要对多药耐药菌患者进行更彻底的治疗,以严格遵守 CRE 预防和管理指南。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验